0001179110-16-033197.txt : 20161219 0001179110-16-033197.hdr.sgml : 20161219 20161219163445 ACCESSION NUMBER: 0001179110-16-033197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161215 FILED AS OF DATE: 20161219 DATE AS OF CHANGE: 20161219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Onconova Therapeutics, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3681 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kumar Ramesh CENTRAL INDEX KEY: 0001580074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 162059331 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 4 1 edgar.xml FORM 4 - X0306 4 2016-12-15 0 0001130598 Onconova Therapeutics, Inc. ONTX 0001580074 Kumar Ramesh C/O ONCONOVA THERAPEUTICS, INC. 375 PHEASANT RUN NEWTOWN PA 18940 1 1 0 0 President and CEO Stock Option (right to purchase) 2.65 2016-12-15 4 A 0 12673 0 A 2026-12-15 Common Stock 12673 12673 D These options vest over three years in 36 equal monthly installments. /s/ Mark Guerin as attorney-in-fact 2016-12-19